Importantly, we saw increased expression of cellular senescence markers (gain of KLRG1 and loss of CD28) and accelerators of cell cycle arrest (CDKN1A, CCND3) and senescence (HRAS)19 in patients with early and established RA [Fig. 1h]. This evidence concerns the gene CCND3 and rheumatoid arthritis.